KLOW80 80 mg

KLOW80 is a multi-component research blend containing GHK-Cu, KPV, BPC-157 and TB-500. GHK-Cu is a copper complex of glycyl-L-histidyl-L-lysine, a tripeptide composed of three amino acids. KPV is a tripeptide consisting of lysine, proline and valine. BPC-157 is a synthetic peptide studied in preclinical biological research. TB-500 is the commercial name used for the intended full-length thymosin beta-4 material, a peptide associated with research into cellular processes and actin interactions. The stated total content is 80 mg per vial, comprising 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157 and 10 mg TB-500. This product is supplied as lyophilised powder for laboratory research and analytical investigation only. Refer to the product specification for the stated composition and to available batch documentation for the analytical assessments performed.

This material is supplied solely for legitimate laboratory and analytical research. It must not be used in or administered to humans or animals, consumed personally, or used to prepare medicines, supplements or cosmetics for such use. Review the product specification and available batch documentation before ordering.

KEY DETAILS

• Product: KLOW80 80 mg
• Chemical identity: Multi-component blend of GHK-Cu (copper complex of glycyl-L-histidyl-L-lysine), KPV (lysine-proline-valine tripeptide), BPC-157 (synthetic peptide) and TB-500 (intended full-length thymosin beta-4).
• Contents per vial: 80 mg total
• Components: 50 mg GHK-Cu, 10 mg KPV, 10 mg BPC-157 and 10 mg TB-500
• Physical form: Lyophilised powder
• Batch documentation: See the Certificates of Analysis (CoA) page for available batch-specific reports.
• Storage: Refrigeration required.
• Intended use: Laboratory and analytical research only. Not for human or veterinary use.